Consolidated Statements of Operations - USD ($)	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Operating expenses:
Research and development	$ 9,660,150	$ 4,529,358
General and administrative	11,946,702	5,793,764
Loss from operations	(21,606,852)	(10,323,122)
Loss (income) on equity method investment	33,295	(2,548)
Interest Income, net	(48,881)	(188,677)
Loss from change in fair value of promissory notes	1,304,000	993,000
(Gain) loss from change in fair value of warrant liability	(40,272,880)	53,342
Net income (loss)	$ 17,377,614	$ (11,178,239)
Per share information:
Net income (loss) per share of common stock, basic (in dollars per share)	$ 0.72	$ (0.86)
Net income (loss) per share of common stock, diluted (in dollars per share)	$ 0.72	$ (0.86)
Weighted average shares outstanding, basic (in shares)	24,233,957	13,012,833
Weighted average shares outstanding, diluted (in shares)	24,233,957	13,012,833